34046-43-0Relevant articles and documents
THIAZOLE DERIVATIVE AND APPLICATIONS
-
Paragraph 0099-0100, (2019/04/16)
A thiazole derivative serving as a DHODH inhibitor, and applications thereof. The present invention specifically relates to a compound represented by formula I, a pharmaceutical composition containing the compound represented by formula (I), and applications of the compound in the preparation of drugs for treating diseases mediated by the DHODH or drugs for inhibiting the DHODH.
Cobalt(ii)-catalyzed benzylic oxidations with potassium persulfate in TFA/TFAA
Li, Tianlei,Li, Jishun,Zhu, Zihao,Pan, Weidong,Wu, Song
, p. 20879 - 20883 (2019/07/12)
A cobalt-catalyzed C(sp3)-H oxygenation reaction to furnish aldehyde was herein reported. This transformation demonstrated high chemo-selectivity, and tolerated various methylarenes bearing electron-withdrawing substituents. This reaction provided rapid access to diverse aldehydes form methylarenes. Notably, TFA/TFAA was used for the first time as a mixed solvent in cobalt-catalyzed oxygenation of benzylic methylenes.
METHYL OXAZOLE OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 35, (2016/06/28)
The present invention is directed to methyl oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.